Throughout the above report, an intriguing phenomenon has emerged: regardless of the regulatory relationship between LSD1 and PD-L1, the combined blockade of PD-(L)1 and inhibition of LSD1 has shown effectiveness in suppressing tumor growth across various cancer types. Here, KDM1A is linked to cancer.